产品分类导航
Enoxaparin sodium injection
Enoxaparin sodium injection
Enoxaparin sodium injection

Enoxaparin sodium injection

更新时间:2025-02-07

价格:
地区: 成都市
是否提供样品:
立即询盘
收藏
产品详情
主要销售市场: 北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲
产品描述:

Active ingredients: enoxaparin sodium, molecular weight: average molecular weight is between 3800-5000 daltons.
Description: clear, colorless to pale yellow clear liquid.      

Dosage Form: liquid injection.                                                                           
Indications:

1. Prophylaxis of venous thromboembolic diseases (the generation of venous thrombosis), specially orthopedic or general surgery-related thrombosis;

2. For acute deep vein thrombosis, with or without pulmonary embolism and when symptoms are not obvious. Exclude pulmonary embolism which requires surgery and thrombolytic therapy;

3. Treatment of unstable Angina and Non-Q-Wave Myocardial infarction, when concurrently administered with aspirin;

4. Hemodialysis in vitro circulation, to prevent thrombosis.
Strength:0.6ml:6000AxaIU

Storage: Keep airtight in a cool place.
Packaging: 10 bottles/box, 100 boxes/carton (Can be customized based on customer's order.)

Shelf Life: 24months.

四川宏明博思药业有限公司
注册资本不愿意公开
公司地址
四川省成都市成都高新区合作路343号
联系人
联系电话
查看联系方式
快速询盘
询盘主题
请输入询盘主题
询盘信息
请输入询盘信息
滑动验证
请完成滑块验证
快速发送询盘
CPHI制药在线为您找到Enoxaparin sodium injection 价格、Enoxaparin sodium injection 详细参数、Enoxaparin sodium injection 相关产品、Enoxaparin sodium injection 供应商等信息,想了解当前Enoxaparin sodium injection 最新报价,请联系四川宏明博思药业有限公司。
2006-2025 上海博华国际展览有限公司版权所有(保留一切权利) 沪ICP备05034851号-57